Endothelium and cardioprotectiv effects of HMG Co-A reductase in combination with L-arginin endotelial dysfunction in modeling
Using the combined of L-arginine with inhibitors of HMG-Co-A reductase simvastatin, atorvastatin, rosuvastatin and rosuvastatin nanopartikulirovannym on background modeling endotoxin-induced disease, the introduction of strain 603 Staphylococcusaureus shows endotelio- and cardioprotective effects, m...
Main Authors: | T. A. Denisyuk, M. V. Pokrovsky, O. V. Filippova, A. A. Dolzhikov, T. G. Pokrovskaya, M. V. Korokin, O. A. Osipova, A. I. Lazarev, G. A. Lazareva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2016-04-01
|
Series: | Кубанский научный медицинский вестник |
Subjects: | |
Online Access: | https://ksma.elpub.ru/jour/article/view/486 |
Similar Items
-
Endotelioand cardioprotective effects of HMG-Co-A reductase in endotoksininducing endotelial dysfunction
by: T. A. Denisuk, et al.
Published: (2016-06-01) -
Endotelioand cardioprotective effects of HMG-Co-A reductase in endotoksininducing endotelial dysfunction
by: T. A. Denisuk, et al.
Published: (2015-10-01) -
Combined use of statins and inhibitors of arginase l-norvaline for correcting endotoksin-inducing endotelial dysfunction
by: T. A. Denisyuk, et al.
Published: (2016-02-01) -
ASSOCIATION OF POLYMORPHISM RS3846663 IN HMG-CoA REDUCTASE GENE WITH THE EFFECTIVENESS OF STATIN THERAPY IN PATIENTS WITH CORONARY HEART DISEASE
by: Aleksey Vladimirovich Osedko, et al.
Published: (2019-05-01) -
Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase
by: T. A. Denisyuk, et al.
Published: (2015-12-01)